Results 151 to 160 of about 61,568 (292)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2404-2416, August 2025.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna   +4 more
wiley   +1 more source

Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles

open access: yesImmunological Medicine
In recent years, various myositis-specific and myositis-associated autoantibodies have been identified in idiopathic inflammatory myopathies, including dermatomyositis (DM), anti-synthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), and
Mariko Ogawa-Momohara, Yoshinao Muro
doaj   +1 more source

Hyperbaric oxygen therapy services at the Pamela Youde Nethersole Eastern Hospital hyperbaric oxygen therapy Center: A retrospective epidemiological study

open access: yesHong Kong Journal of Emergency Medicine, Volume 32, Issue 4, August 2025.
Abstract Introduction The aim of this retrospective epidemiological study is to analyze the characteristics and caseload of patients treated at the Pamela Youde Nethersole Eastern Hospital (PYNEH) hyperbaric oxygen therapy (HBOT) Center in Hong Kong from 2018 to 2023 to gain insight into the HBOT service provision and development in HK.
Kin Bong Tang   +2 more
wiley   +1 more source

Gold Laser Cricopharyngeal Myectomy for Cricopharyngeal Dysfunction

open access: yesThe Laryngoscope, Volume 135, Issue 8, Page 2713-2719, August 2025.
Endoscopic treatment for cricopharyngeal bar with or without diverticulum has become the preferred option in management. However, critics cite high recurrence rates. This study evaluated a modified endoscopic approach of cricopharyngeal myectomy, removing a block of tissue with a Gold laser, to treat 84 patients with CP bar, demonstrating significantly
Jacqui Allen   +4 more
wiley   +1 more source

Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL

open access: yesMuscle &Nerve, Volume 72, Issue 2, Page 230-239, August 2025.
A total of 95 ERT‐experienced adults with LOPD were randomized to switch to cipaglucosidase alfa + miglustat or remain on alglucosidase alfa treatment. After 52 weeks, patients remaining on alglucosidase alfa showed worsening or stability for most outcomes, whereas patients who switched to cipaglucosidase alfa + miglustat generally showed stability or ...
Hani Kushlaf   +17 more
wiley   +1 more source

The Role of Repeat Skeletal Muscle Biopsy: Indications, Yield and Outcomes

open access: yesMuscle &Nerve, Volume 72, Issue 2, Page 217-223, August 2025.
ABSTRACT Introduction/Aims Muscle biopsy performed to investigate weakness and/or pain may be nondiagnostic and prompt repeat biopsy. We determined the indications and yield of rebiopsy. Methods Patients who underwent > 1 muscle biopsy (South Australia, 2000–2023) were identified.
Thomas Khoo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy